ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 48 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $103,354,000 | +11.9% | 1,951,183 | -39.0% | 7.43% | -5.4% |
| Q1 2015 | $92,386,000 | -0.8% | 3,201,183 | 0.0% | 7.86% | +4.3% |
| Q4 2014 | $93,122,000 | +129.4% | 3,201,183 | 0.0% | 7.53% | +90.3% |
| Q3 2014 | $40,591,000 | -68.4% | 3,201,183 | -50.0% | 3.96% | -38.5% |
| Q2 2014 | $128,496,000 | – | 6,402,366 | – | 6.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |